Becker Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.87M | Sell |
7,869
-179
| -2% | -$97.1K | 0.11% | 109 |
|
|
2025
Q4 | $4.67M | Buy |
8,048
+24
| +0.3% | +$13.6K | 0.13% | 103 |
|
|
2025
Q3 | $3.9M | Sell |
8,024
-6
| -0.1% | -$2.79K | 0.11% | 113 |
|
|
2025
Q2 | $3.26M | Sell |
8,030
-28
| -0.3% | -$11.7K | 0.1% | 116 |
|
|
2025
Q1 | $4.01M | Sell |
8,058
-143
| -2% | -$77.4K | 0.13% | 110 |
|
|
2024
Q4 | $4.27M | Sell |
8,201
-125
| -2% | -$68.7K | 0.14% | 104 |
|
|
2024
Q3 | $5.15M | Buy |
8,326
+23
| +0.3% | +$13.6K | 0.17% | 98 |
|
|
2024
Q2 | $4.59M | Buy |
8,303
+100
| +1% | +$57.3K | 0.16% | 104 |
|
|
2024
Q1 | $4.77M | Hold |
8,203
| – | – | 0.16% | 101 |
|
|
2023
Q4 | $4.36M | Sell |
8,203
-112
| -1% | -$54.2K | 0.16% | 100 |
|
|
2023
Q3 | $4.21M | Sell |
8,315
-765
| -8% | -$408K | 0.17% | 99 |
|
|
2023
Q2 | $4.74M | Buy |
9,080
+320
| +4% | +$173K | 0.18% | 96 |
|
|
2023
Q1 | $5.05M | Sell |
8,760
-12
| -0.1% | -$6.76K | 0.2% | 93 |
|
|
2022
Q4 | $4.83M | Sell |
8,772
-40
| -0.5% | -$21.2K | 0.23% | 87 |
|
|
2022
Q3 | $4.47M | Hold |
8,812
| – | – | 0.23% | 86 |
|
|
2022
Q2 | $4.79M | Sell |
8,812
-61
| -0.7% | -$33.6K | 0.23% | 89 |
|
|
2022
Q1 | $5.24M | Sell |
8,873
-212
| -2% | -$122K | 0.21% | 91 |
|
|
2021
Q4 | $6.06M | Buy |
9,085
+353
| +4% | +$220K | 0.24% | 88 |
|
|
2021
Q3 | $4.99M | Buy |
8,732
+5
| +0.1% | +$2.74K | 0.21% | 89 |
|
|
2021
Q2 | $4.4M | Sell |
8,727
-2
| -0% | -$944 | 0.19% | 94 |
|
|
2021
Q1 | $3.98M | Hold |
8,729
| – | – | 0.18% | 96 |
|
|
2020
Q4 | $4.07M | Sell |
8,729
-304
| -3% | -$143K | 0.2% | 89 |
|
|
2020
Q3 | $3.99M | Sell |
9,033
-106
| -1% | -$43.8K | 0.22% | 84 |
|
|
2020
Q2 | $3.31M | Sell |
9,139
-200
| -2% | -$67K | 0.19% | 86 |
|
|
2020
Q1 | $2.65M | Sell |
9,339
-24
| -0.3% | -$7.57K | 0.16% | 87 |
|
|
2019
Q4 | $3.04M | Sell |
9,363
-34
| -0.4% | -$10.3K | 0.11% | 88 |
|
|
2019
Q3 | $2.74M | Buy |
9,397
+82
| +0.9% | +$23.5K | 0.1% | 85 |
|
|
2019
Q2 | $2.74M | Hold |
9,315
| – | – | 0.1% | 85 |
|
|
2019
Q1 | $2.55M | Buy |
9,315
+3,705
| +66% | +$922K | 0.09% | 88 |
|
|
2018
Q4 | $1.25M | Hold |
5,610
| – | – | 0.05% | 92 |
|
|
2018
Q3 | $1.37M | Hold |
5,610
| – | – | 0.04% | 96 |
|
|
2018
Q2 | $1.16M | Sell |
5,610
-979
| -15% | -$208K | 0.04% | 96 |
|
|
2018
Q1 | $1.36M | Buy |
6,589
+3,619
| +122% | +$760K | 0.05% | 91 |
|
|
2017
Q4 | $564K | Buy |
2,970
+898
| +43% | +$172K | 0.02% | 113 |
|
|
2017
Q3 | $392K | Buy |
+2,072
| New | +$375K | 0.01% | 119 |
|
Other funds holding TMO
VCM
Becker Capital Management's TMO Position: Q1 2026 in Review
Becker Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 2.2% in Q1 2026, selling an estimated $97.1K and leaving 7,869 shares worth $3.87M. The position accounts for 0.11% of the portfolio, ranked #109.
Becker Capital Management first reported a position in TMO in Q3 2017 and has held it in 35 quarters since. The position peaked at $6.06M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Becker Capital Management held 7,869 shares of Thermo Fisher Scientific worth $3.87M as of Q1 2026.
- Becker Capital Management sold 179 Thermo Fisher Scientific shares in Q1 2026, an estimated $97.1K.
- Thermo Fisher Scientific made up 0.11% of Becker Capital Management's portfolio in Q1 2026, its #109 holding.
- Becker Capital Management first reported a position in Thermo Fisher Scientific in Q3 2017 and has held it in 35 quarters since.
- Becker Capital Management's Thermo Fisher Scientific position peaked at $6.06M in Q4 2021.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Becker Capital Management's 13F filing for Q1 2026, filed 11 May 2026.